Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Sep 1;95(18):10836-41.
doi: 10.1073/pnas.95.18.10836.

Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2

Affiliations

Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2

L Yang et al. Proc Natl Acad Sci U S A. .

Abstract

A series of nonpeptide somatostatin agonists which bind selectively and with high affinity to somatostatin receptor subtype 2 (sst2) have been synthesized. One of these compounds, L-054,522, binds to human sst2 with an apparent dissociation constant of 0.01 nM and at least 3,000-fold selectivity when evaluated against the other somatostatin receptors. L-054,522 is a full agonist based on its inhibition of forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary-K1 cells stably expressing sst2. L-054,522 has a potent inhibitory effect on growth hormone release from rat primary pituitary cells and glucagon release from isolated mouse pancreatic islets. Intravenous infusion of L-054,522 to rats at 50 microgram/kg per hr causes a rapid and sustained reduction in growth hormone to basal levels. The high potency and selectivity of L-054, 522 for sst2 will make it a useful tool to further characterize the physiological functions of this receptor subtype.

PubMed Disclaimer

Figures

Figure 1
Figure 1
sst 2-Selective leads.
Figure 2
Figure 2
Important analogs of L-054,522.
Figure 3
Figure 3
Superposition of modeled conformations of compound 7 (L-054,522, green) upon cyclic peptide 9 (magenta). Both structures incorporate the available NMR data and have been energy minimized with MMFF94(s).
Figure 4
Figure 4
Receptor subtype potencies of somatostatin and several important analogs.
Figure 5
Figure 5
Inhibition of forskolin-stimulated cAMP accumulation. cAMP accumulation in forskolin-stimulated mouse L cells stably transfected with sst2 was measured in the presence of increasing concentrations of somatostatin-14 or L-054,522. Each point is the average of three determinations, replicate experiments gave similar results.
Figure 6
Figure 6
Plasma GH levels were measured every 10 min for a 24-hr period. At 1300 hr the animals were infused with either L-054,522 (50 μg/kg per hr) or vehicle (0.25% dimethyl sulfoxide) for 11 hr. Replicate experiments gave similar results.

References

    1. Epelbaum J. Prog Neurobiol. 1986;27:63–100. - PubMed
    1. Raynor K, Reisine T. Crit Rev Neurobiol. 1992;16:273–289. - PubMed
    1. Reichlin S. N Engl J Med. 1983;309:1495–1503. - PubMed
    1. Brazeau P, Vale W, Burgus R, Ling N, Rivier J, Guillemin R. Science. 1972;129:77–79. - PubMed
    1. Pradayrol L, Jornvall H, Mutt V, Ribet A. FEBS Lett. 1980;109:55–58. - PubMed

LinkOut - more resources